In an effort to develop adult stem cell therapies that are specifically targeted to counteracting the biological dangers of nuclear warfare, the U.S. Deparment of Defense has awarded a $224.7 million contract to an Osiris-Genzyme partnership.
Researchers at the Washington University School of Medicine in St. Louis lead a nationwide, multicenter clinical trial to study the efficacy of adult stem cell therapy in the treatment of children with sickle cell anemia.
Scientists at the Joslin Diabetes Center in Boston offer the first evidence that adult stem cells derived from muscle constitute a viable therapy for muscular dystrophy in an animal model.
Stempeutics Research, headquartered near Bangalore, India, is currently developing broad stem cell therapies that are applicable to a wide variety of diseases.
The pharmaceutical company Pfizer is helping to create a new company dedicated to the development of adult stem cell therapies for diabetes-induced retinal damage.
Researchers discover stem cell precursors of cardiomyocytes located in the outer layer of heart tissue.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.